Healthtech innovator, Qure.ai, has devised an artificial intelligence (AI)-empowered virtual healthcare platform, potentially predicting high-risk patients before they reach emergency rooms.
With deployments already underway across Europe and South Asia
, Qure.ai is now in discussions with various levels of government for potential rollout in public hospitals and healthcare centers.
The Mumbai-based startup, bolstered by recent $16 million funding from Sequoia Capital India and Mass Mutual Ventures, has created the app-based qScout solution.
This tool, designed for frontline healthcare workers, facilitates remote triaging, contact tracing of Covid-19 patients, and hotspot mapping for efficient supply chain management and test kit distribution.
Prashant Warier, CEO and Co-founder of Qure.ai asserts that qScout helps track, manage, and prioritize testing, improving diagnosis without overloading existing healthcare infrastructure. Leveraging their vast experience with AI solutions and deep learning technology, Qure.ai is reinventing radiology by enhancing imaging accuracy, speeding up diagnoses and treatment times, and making healthcare more affordable and accessible worldwide.
The company's existing chest X-ray automation and interpretation solution, capable of detecting multiple conditions, has been further developed to identify Covid-19 indicators and quantify lung damage. This added feature will aid healthcare professionals in screening and monitoring Covid-19 patients.